| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Ken Takanashi | Director, 10%+ Owner | $22.6M | Jun 6, 2023 | ||
| Shin Nippon Biomedical Laboratories, Ltd. | 10%+ Owner | $10M | Jun 6, 2023 | ||
| Braden Michael Leonard | 10%+ Owner | $6M | Nov 21, 2022 | ||
| Commodore Capital Lp | 10%+ Owner | $326K | Nov 14, 2022 | ||
| Rajeev M. Shah | Director, 10%+ Owner | Jun 6, 2023 | |||
| Mutya Harsch | Director | Jun 8, 2023 | |||
| Detlef Albrecht | Chief Medical Officer | Jun 3, 2022 | |||
| Thomas B. King | Director | Jun 8, 2023 | |||
| Ra Capital Management, L.P. | Former 10% Owner | Jun 8, 2023 | |||
| Michael T. Riebe | Director | Jun 8, 2023 | |||
| Heath Lukatch | Director | Jun 8, 2023 | |||
| John A. Kollins | President and CEO, Director | Jun 6, 2023 | |||
| Thomas P. O'Neil | Chief Financial Officer | Jun 6, 2023 | |||
| Thomas P. Soloway | Director | Jun 8, 2023 | |||
| Elisabeth Sandoval | Director | Jun 8, 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|